… We describe the primary objectives of the quadrivalent HPV vaccine clinical trial program …
well as programs to evaluate vaccine impact on oropharyngeal cancer are also described. …

… cancer is the greatest cause of cancer death in women in many developing countries; HPV
vaccines are highly effective in preventing HPV … area of cancer control is the control of chronic …

… of remarkable population effectiveness against human papillomavirus (HPV), with virtual …
after vaccination of the young Australian female population with the quadrivalent HPV vaccine (…

… This of course assumes that an HPV vaccine will be efficacious against cancer and long …
concerned with cervical cancer control to consider the progress in research on vaccines within a …

… screening programme at this juncture is at all practicable or we should straightaway settle
for a HPV vaccine based primary prevention strategy. In addition to the huge logistics and …

… to consider whether and how to use these new vaccines. This … on HPV and HPV vaccines
for policy-makers. It is based on a longer document (“Human Papillomavirus and HPV vaccines…

… 37 Franco EL, Cuzick J, Hildesheim A, de Sanjose S: Issues in planning cervical cancer
screening in the era of HPV vaccination. Vaccine 2006; 24(suppl 3):S171–S177. 38 Wright TC Jr…

… Population-relevant domains are: 1) HPV vaccination in pre-… 2) HPV vaccination in older
individuals; 3) targeted vaccination … and HPV vaccination approaches and 7) alternative vaccine …

… theory of HPV vaccine herd effects … vaccine herd effects have now been observed worldwide.
In this paper, we review the theory of vaccine herd effects in the context of HPV vaccination …

… Further, to exclude possible prevalent cervical cancers at the date of HPV vaccination, we
used a buffer period of 1 to 5 years at 1-year intervals after the index date of HPV vaccination (…